Access Pharmaceuticals Signs Agreement with Major Global Pharmaceutical Company for Its CobOral Oral Insulin Formulation

Access Pharmaceuticals Signs Agreement with Major Global Pharmaceutical Company for Its CobOral Oral Insulin Formulation
ACCESS PHARMACEUTICALS, INC. , a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major global pharmaceutical company to test Access' oral insulin formulation based upon its proprietary vitamin B-12-based CobOral⢠Drug Delivery Technology ...

Read more on PR Newswire via Yahoo! Finance

---

Orignal From: Access Pharmaceuticals Signs Agreement with Major Global Pharmaceutical Company for Its CobOral Oral Insulin Formulation